About: http://webisa.webdatacommons.org/23485393

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Otherwise, AZN, like many drug companies, faces headwinds related to slower growth, upcoming patent expirations which then leads to generic competition, pipeline less than stellar and other issues inherent in the pharma field.
http://www.w3.org/ns/prov#wasQuotedFrom	philstockworld.com